Comparison of three cardioverter defibrillator implantation techniques: Initial results with transvenous pectoral implantation

被引:16
作者
Anvari, A
Stix, G
Grabenwoger, M
Schneider, B
Turel, Z
Schmidinger, H
机构
[1] UNIV VIENNA,DEPT CARDIOTHORAC SURG,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,INST MED STAT & DOCUMENTAT,A-1090 VIENNA,AUSTRIA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1996年 / 19卷 / 07期
关键词
ventricular tachycardia; ventricular fibrillation; implantable cardioverter defibrillator;
D O I
10.1111/j.1540-8159.1996.tb03414.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 121 patients underwent epicardial (n = 32), transvenous abdominal (n = 30), and transvenous pectoral (n = 59) ICD implants. Perioperative complications were defined as those occurring within 30 days after surgery. Hospital costs were calculated with $750 per day as a fixed charge. Duration of surgery was the time between the first skin incision and the last skin suture. Severe perioperative complications that were life-threatening or required surgical intervention occurred in the epicardial (6%) and transvenous (10%) abdominal groups, but not in the pectoral group. Perioperative mortality occurred only in the epicardial abdominal group, predominantly inpatients with concomitant surgery (18%), and in 5% of patients without concomitant surgery. The duration of surgery was significantly shorter for transvenous pectoral implantation (58 +/- 15 min, P < 0.05) compared to transvenous abdominal implantation (115 +/- 38 min). Epicardial abdominal ICD implantation had the longest procedure time (154 +/- 31 min). The postimplant hospital length of stay was significantly shorter for pectoral implantation (5 +/- 3 days, P < 0.05) compared to transvenous (13 +/- 5) and epicardial (19 +/- 5) abdominal implantation. Total hospitalization costs significantly decreased in the pectoral implantation group ($4,068 +/- $2,099 for the pectoral group vs $14,887 +/- $4,415 and $9,975 +/- $3,657 for the epicardial and the transvenous abdominal group, respectively, P < 0.05). These initial results demonstrate the advantage of transvenous pectoral ICD implantation in terms of perioperative complications, procedure time, hospital length of stay, and hospitalization costs.
引用
收藏
页码:1061 / 1069
页数:9
相关论文
共 17 条
[1]  
BARBOLA J, 1988, ARCH INTERN MED, V142, P70
[2]   A SIMPLIFIED, SINGLE-LEAD UNIPOLAR TRANSVENOUS CARDIOVERSION-DEFIBRILLATION SYSTEM [J].
BARDY, GH ;
JOHNSON, G ;
POOLE, JE ;
DOLACK, GL ;
KUDENCHUK, PJ ;
KELSO, D ;
MITCHELL, R ;
MEHRA, R ;
HOFER, B .
CIRCULATION, 1993, 88 (02) :543-547
[3]   CLINICAL-EXPERIENCE WITH A TIERED-THERAPY, MULTIPROGRAMMABLE ANTIARRHYTHMIA DEVICE [J].
BARDY, GH ;
TROUTMAN, C ;
POOLE, JE ;
KUDENCHUK, PJ ;
DOLACK, GL ;
JOHNSON, G ;
HOFER, B .
CIRCULATION, 1992, 85 (05) :1689-1698
[4]   IMPLANTABLE TRANSVENOUS CARDIOVERTER-DEFIBRILLATORS [J].
BARDY, GH ;
HOFER, B ;
JOHNSON, G ;
KUDENCHUK, PJ ;
POOLE, JE ;
DOLACK, GL ;
GLEVA, M ;
MITCHELL, R ;
KELSO, D .
CIRCULATION, 1993, 87 (04) :1152-1168
[5]  
FORGOROS RN, 1990, J AM COLL CARDIOL, V16, P381
[6]  
FROMER M, 1991, PACE, V141, P1288
[7]  
GARTMAN DM, 1990, J THORAC CARDIOV SUR, V100, P353
[8]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS AND SURVIVAL IN PATIENTS WITH MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
KELLY, PA ;
CANNOM, DS ;
GARAN, H ;
MIRABAL, GS ;
HARTHORNE, JW ;
HURVITZ, RJ ;
VLAHAKES, GJ ;
JACOBS, ML ;
ILVENTO, JP ;
BUCKLEY, MJ ;
RUSKIN, JN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) :1278-1286
[9]   AN ANALYSIS OF THE COST-EFFECTIVENESS OF THE IMPLANTABLE DEFIBRILLATOR [J].
KUPPERMANN, M ;
LUCE, BR ;
MCGOVERN, B ;
PODRID, PJ ;
BIGGER, JT ;
RUSKIN, JN .
CIRCULATION, 1990, 81 (01) :91-100
[10]   COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFECT OF IMPROVED BATTERY LIFE AND COMPARISON WITH AMIODARONE THERAPY [J].
LARSEN, GC ;
MANOLIS, AS ;
SONNENBERG, FA ;
BESHANSKY, JR ;
ESTES, NAM ;
PAUKER, SG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) :1323-1334